Skip to content

MRI to optimise lung cancer radiotherapy

Using lung ventilation imaging to optimise lung cancer radiotherapy plans

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10891735
Enrollment
20
Registered
2023-12-18
Start date
2023-12-01
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer Cancer

Interventions

Patients who meet the study inclusion criteria who attend outpatient cancer care clinics at Newcastle upon Tyne Hospitals NHS Foundation Trust will be identified by members of the study team. They wil

Sponsors

Newcastle upon Tyne Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 and over 2. Able to provide written informed consent to participate in the study 3. English speakers 4. Body weight within minimum and maximum scanner requirements of 50-100 kg 5. Diagnosed with non-small cell lung cancer by the clinical team 6. Planned to receive radical OR high dose palliative radiotherapy (+/- adjuvant chemotherapy or surgery)

Exclusion criteria

Exclusion criteria: 1. Patients below the age of 18 years 2. Patients who are not able or decline to give informed consent to participate in the study 3. Non-English speakers 4. Body habitus incompatible with positioning within the MRI scanner sensor used for 19F-MRI (approximately equivalent to a body circumference > 120cm at chest height, and body mass index > 35 kg/m²) 5. Pregnant or breastfeeding 6. MRI contraindications: incompatible implanted medical device (e.g. cardiac pacemaker), or metallic implants incompatible with MRI 7. Claustrophobia incompatible with MRI

Design outcomes

Primary

MeasureTime frame
The percentage of ventilated lung volume (%VV) measured using fluorine MRI study data to characterise the extent of lung ventilation defects in the lungs of lung cancer patients before radiotherapy (single scan, baseline) at one time point

Secondary

MeasureTime frame
Regional tracer gas wash-in and wash-out rates measured using the fluorine MRI scan, and clinical lung function measured using spirometry at baseline

Countries

United Kingdom

Contacts

Public ContactResearch Activity Co-ordinator and Study Co-ordinator
nuth.projectmanagement@nhs.netNone provided

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026